You are viewing an incomplete version of our website. Please click to reload the website as full version.

Tenascin C (TNC) antibody

Details for Product No. ABIN108414, Supplier: Log in to see
Antigen
  • tn
  • 150-225
  • GMEM
  • GP
  • HXB
  • JI
  • TN
  • TN-C
  • AI528729
  • C130033P17Rik
  • Hxb
  • Ten
  • cytotactin
  • tenascin-C
  • P230
  • tenc
  • wu:fk04d02
Reactivity
Human
191
51
43
5
2
2
1
1
1
1
1
Host
Mouse
115
75
13
4
3
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
18
16
12
2
2
2
2
2
2
2
2
2
1
1
1
1
1
Application
Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
129
85
49
48
24
22
22
18
11
8
5
4
1
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Immunogen Monoclonal antibody (Mab) to tenascin-C is derived from the hybridoma produced by fusion between myeloma cells and Balb/c spleen cells. Purified tenascin-C from human fetal fibroblasts was used as an immunogen.
Clone EB2
Isotype IgG1
Specificity The antibody reacts with the 4th and 5th fibronectin-like repeats of human tenascin-C polypeptides of Mr 250000 and 180000. The antibody crossreacts with human, guinea pig and rabbit
Alternative Name Tenascin C (TNC Antibody Abstract)
Background Monoclonal Antibody to Human Extracellular Matrix Components
Research Area Extracellular Matrix
Pathways
Application Notes No reactivity with paraffin sections. Working dilution in westem blotting is at least 1:1000.
Restrictions For Research Use only
Storage 4 °C
Supplier Images
 image for anti-Tenascin C (TNC) antibody (ABIN108414) Carcinoma in situ, vulva (MAb EB2, tenascin)
Immunohistochemistry (IHC) image for anti-Tenascin C (TNC) antibody (ABIN108414) anti-Tenascin C (TNC) antibody (Image 2)
Background publications Li TF, Warris V, Ma J et al.: "Distribution of tenascin-X in different synovial samples and synovial membrane-like interface tissue from aseptic loosening of total hip replacement." in: Rheumatol Int, Vol. 19, Issue 5, pp. 177-83, 2007 (PubMed).

Korhonen, Ormio, Burgeson et al.: "Unaltered distribution of laminins, fibronectin, and tenascin in celiac intestinal mucosa." in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, Vol. 48, Issue 7, pp. 1011-20, 2000 (PubMed).

Karjalainen, Laitinen, Sue-Chu et al.: "Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine." in: American journal of respiratory and critical care medicine, Vol. 161, Issue 6, pp. 2086-91, 2000 (PubMed).

Feng, Yang, Huang et al.: "Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells." in: Circulation research, Vol. 85, Issue 12, pp. 1118-23, 2000 (PubMed).

Järvinen, Jozsa, Kannus et al.: "Mechanical loading regulates tenascin-C expression in the osteotendinous junction." in: Journal of cell science, Vol. 112 Pt 18, pp. 3157-66, 2000 (PubMed).

Yamamoto, Dang, Kennedy et al.: "Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species." in: The Journal of biological chemistry, Vol. 274, Issue 31, pp. 21840-6, 1999 (PubMed).

Kaarteenaho-Wiik R, Mertaniemi P, Sajanti E et al.: "Tenascin is increased in epithelial lining fluid in fibrotic lung disorders." in: Lung, Vol. 176, Issue 6, pp. 371-80, 1998 (PubMed).

Ribatti D, Loverro G, Vacca A et al.: "Expression of tenascin is related to angiogenesis in pre-eclampsia." in: Eur J Clin Invest, Vol. 28, Issue 5, pp. 373-8, 1998 (PubMed).

Laitinen A, Altraja A, Kampe M et al.: "Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid." in: Am J Respir Crit Care Med, Vol. 156, Issue 3 Pt 1, pp. 951-8, 1997 (PubMed).

Tuori, Virtanen, Aine et al.: "The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea." in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, Vol. 235, Issue 4, pp. 222-9, 1997 (PubMed).

Lohi J, Leivo I, Tani T et al.: "Laminins, tenascin and type VII collagen in colorectal mucosa." in: Histochem J, Vol. 28, Issue 6, pp. 431-40, 1996 (PubMed).

Kaarteenaho-Wiik R, Tani T, Sormunen R et al.: "Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia." in: Am J Respir Crit Care Med, Vol. 154, Issue 2 Pt 1, pp. 511-8, 1996 (PubMed).

Vesaluoma, Ylätupa, Mertaniemi et al.: "Increased release of tenascin in tear fluid after photorefractive keratectomy." in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, Vol. 233, Issue 8, pp. 479-83, 1996 (PubMed).

Linnala, Kinnula, Laitinen et al.: "Transforming growth factor-beta regulates the expression of fibronectin and tenascin in BEAS 2B human bronchial epithelial cells." in: American journal of respiratory cell and molecular biology, Vol. 13, Issue 5, pp. 578-85, 1995 (PubMed).

Koukoulis, Gould, Bhattacharyya et al.: "Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications." in: Human pathology, Vol. 22, Issue 7, pp. 636-43, 1991 (PubMed).

Howeedy, Virtanen, Laitinen et al.: "Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast." in: Laboratory investigation, a journal of technical methods and pathology, Vol. 63, Issue 6, pp. 798-806, 1991 (PubMed).